A review flags acute kidney injury as an under-counted toll of Yemen's cholera crisis
Severe dehydration from diarrhoeal disease and sepsis can shut down the kidneys. In a health system with little dialysis, a review argues this is a preventable driver of death that surveillance is missing.
Acute kidney injury is a sudden loss of kidney function that can follow severe dehydration or bloodstream infection. It is often reversible if caught and treated early, and lethal if it is not. A narrative review published in Public Health Challenges on 2 July argues that it is a substantial and under-recognised cause of death in Yemen — one that sits downstream of the country's cholera and diarrhoeal-disease burden [s1].
The mechanism the review describes
The review's argument runs through a physiological chain. Cholera and other diarrhoeal diseases cause severe volume depletion; sepsis causes circulatory collapse; both reduce blood flow to the kidneys, which can shut down [s1]. In a setting where clean water is scarce and diarrhoeal outbreaks recur, the authors write, the conditions that precipitate acute kidney injury are common — while the means to treat it, chiefly dialysis, are in short supply [s1].
The review consolidated evidence from international databases and grey literature, including humanitarian-agency and regional health-authority sources, covering studies on acute kidney injury in Yemen from 2014 to 2024 [s1]. That decade spans the period of Yemen's large cholera epidemics, which is central to the review's argument: it is looking at kidney injury against the backdrop of one of the largest documented cholera burdens of recent years. It is a synthesis of existing reports rather than a new field study, and it does not produce a single national incidence figure — a gap the authors present as part of the problem rather than an omission of their method.
Who the review says is most affected
The data the authors assemble point to a disproportionate burden among children and internally displaced people living in cholera-endemic governorates [s1]. Most documented cases were associated with hypovolaemia — low circulating blood volume — systemic infection, and a lack of preventive measures [s1]. Shortages of dialysis capacity, delayed diagnosis and underreporting combine, in the review's account, to raise the risk of death [s1].
The link to displacement is not incidental. Displaced populations concentrate in crowded conditions with unreliable water and sanitation — the same conditions that drive cholera — and they often have the least access to the specialist care that acute kidney injury requires.
Children are physiologically more vulnerable to this chain of events than adults. A young child loses fluid faster during severe diarrhoea and has less reserve before circulation is compromised, so the same cholera episode that an adult might survive with oral fluids can progress in a child to the volume depletion that injures the kidneys. In a health system with limited paediatric dialysis, that progression is often not reversible once it reaches the severe stage — which is why the review's emphasis falls so heavily on catching dehydration early rather than treating kidney failure late [s1].
Why it goes uncounted
Part of the review's point is about visibility. Diarrhoeal disease is tracked; deaths that follow days later from kidney failure may be recorded, if at all, as something else. Without diagnostic capacity — the blood tests that identify acute kidney injury — cases are not classified as such, and a cause of death that could be prevented by earlier rehydration and infection control never enters the numbers that shape the response [s1]. A response planned around the cases it can see will under-resource the complication it cannot, which is the practical cost the review attaches to the surveillance gap.
What the review recommends, and the caveats
The authors argue for integrating acute kidney injury prevention into diarrhoeal-disease programmes: scaling up oral rehydration, improving sepsis management, and strengthening community health systems [s1]. Oral rehydration is the relevant intervention because catching volume depletion early, before the kidneys are affected, is far cheaper and more feasible in a low-resource setting than providing dialysis after the fact.
The claims should be read as those of a narrative review. It synthesises heterogeneous sources rather than measuring incidence directly, and its central assertion — that acute kidney injury is under-counted — is by definition difficult to quantify. What it establishes is a plausible, mechanistically coherent case that a treatable complication of Yemen's water and diarrhoeal-disease crisis is being missed, and that the fix lies mostly in prevention rather than in the scarce specialist care [s1]. Health Newspapers is reporting these as the review's findings and is not independently verifying the underlying case data.
Sources
- Beyond the Battlefield: Examining Acute Kidney Injury in Yemen's Humanitarian Crisis — Public Health Challenges (Wiley) , July 2, 2026
More on
NSAIDs raise kidney-injury risk modestly — but sharply in a few specific situations
Across studies, current NSAID use was tied to about a 73% higher odds of acute kidney injury, more in older people and those with existing kidney disease. The combination with two blood-pressure drugs is the real hazard.
Cholera killed 7,598 people in 2025, in fewer countries than two years before
WHO's year-end tally records 614,828 cases across 33 countries. December brought a decline — and the reported figures are known to be a fraction of the true burden.
Global cholera cases fell 17%, but DR Congo still accounts for a third of the toll
WHO's latest tally puts the 2026 year-to-date count at 58,740 cases and 732 deaths across 22 countries, down sharply from last year except in conflict-affected states.
Preventive cholera vaccination restarts after three years, on doses from one manufacturer
Global oral cholera vaccine supply has roughly doubled since 2022, enough to release 20 million doses for prevention rather than outbreak response. Nearly all of it comes from a single company.